Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
Russia accidentally destroys its only way of sending astronauts to space- In vogue Sleepwear Patterns for 2024
- Monetary Strengthening: Assuming Command over Your Cash
- Becoming Familiar with an Unknown dialect: My Language Learning Excursion
- 'You're no longer my sister' - rows erupt as war divides Iranian families
- Recalled Super Greens diet supplement powder sickens 45 with salmonella
- Figure out How to Augment Your Rooftop Substitution Speculation
- Eat Well, Live Well: An Extensive Manual for Smart dieting and Sustenance
- Winona Ryder didn't take the 'Stranger Things' plot lightly. How 'otherworldly' grief and a kidnapping in her hometown informed her character.
